➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Dow
McKesson
Medtronic
Merck

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Corden Pharma Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CORDEN PHARMA, and what generic and branded alternatives to CORDEN PHARMA drugs are available?

CORDEN PHARMA has five approved drugs.



Summary for Corden Pharma
US Patents:0
Tradenames:4
Ingredients:4
NDAs:5

Drugs and US Patents for Corden Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-001 Mar 3, 1989 DISCN Yes No   Start Trial   Start Trial
Corden Pharma VEPESID etoposide INJECTABLE;INJECTION 018768-001 Nov 10, 1983 DISCN Yes No   Start Trial   Start Trial
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-001 Approved Prior to Jan 1, 1982 RX Yes No   Start Trial   Start Trial
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-003 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-002 Mar 3, 1989 DISCN Yes No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Corden Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-001 Mar 3, 1989 4,657,927*PED   Start Trial
Corden Pharma VEPESID etoposide INJECTABLE;INJECTION 018768-001 Nov 10, 1983 3,524,844   Start Trial
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-003 Mar 3, 1989 4,657,927*PED   Start Trial
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-002 Mar 3, 1989 4,657,927*PED   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Baxter
Harvard Business School
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.